Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection

OBJECTIVE: To compare the efficacy of adjuvant chemotherapy with six or eight cycles of S-1 plus oxaliplatin (SOX) or Capecitabine plus oxaliplatin (XELOX) after D2 resection of GC. DESIGN AND PARTICIPANTS: We collected 470 cases of patients with TNM stage II and III GC who underwent D2 gastrectomy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Front Oncol
Hauptverfasser: Yu, Yuanyuan, Zhang, Zicheng, Meng, Qianhao, Ma, Yue, Fan, Xiaona, Sun, Jie, Wang, Guangyu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2021
Schlagworte:
Oncology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181140/
https://ncbi.nlm.nih.gov/pubmed/34109131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.684627
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge